US Patent Family Members and Approved Drugs for China Patent: 101932607
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for China Patent: CN101932607
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Start Trial | 2027-08-23 | evolocumab | Amgen, Inc. | REPATHA |
| ⤷ Start Trial | 2027-08-23 | evolocumab | Amgen, Inc. | REPATHA |
| ⤷ Start Trial | 2027-08-23 | evolocumab | Amgen, Inc. | REPATHA |
| ⤷ Start Trial | 2027-08-23 | evolocumab | Amgen, Inc. | REPATHA |
| ⤷ Start Trial | 2027-08-23 | evolocumab | Amgen, Inc. | REPATHA |
| ⤷ Start Trial | 2027-08-23 | evolocumab | Amgen, Inc. | REPATHA |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
